Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nanocrystalline Megestrol Acetate in cachectic HCC
NCT07356037Phase 3Not yet recruiting
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Start
- Jan 2026
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of megestrol in cachexia, sponsored by Changchun GeneScience Pharmaceutical Co., Ltd.. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
megestrol
03
Conditions
cachexia
Beyond the preview
Go deeper on NCT07356037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07356037.